personalized medicine

Tampa, Florida, U.S., September 22, 2026 Tampa General Hospital has become the first academic health system in the Southeast...

Irvine, California, U.S., September 18, 2026 Avenda Health, an artificial intelligence-powered medical technology company focused on prostate cancer care,...

Melbourne, Australia, September 10, 2026 Nutromics has announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough...

Cambridge, UK, September 8, 2026 AstraZeneca has reported detailed results from the Phase III OBERON and TITANIA trials showing...

Waltham, Massachusetts, USA, September 8, 2026 NanoMosaic has joined a Mass General Brigham-led consortium selected for the Advanced Research...

Austin, Texas – August 28, 2026 Natera, Inc. announced a new national partnership with Susan G. Komen to accelerate...

Rio Rancho, New Mexico, August 19, 2026 NTx Bio is advancing the manufacturing infrastructure supporting personalized cancer vaccines through...

PLEASANTON, Calif., July 29, 2026 10x Genomics has entered a multi-year research collaboration with Lausanne University Hospital (CHUV) to...

LONDON, United Kingdom, July 29, 2026 Smith+Nephew has achieved a significant regulatory milestone after receiving U.S. Food and Drug...

FRIENDSWOOD, Texas, July 14, 2026 Castle Biosciences, Inc. has announced that its AdvanceAD-Tx™ test has received assay approval from...